Bringing the fundamentals into focus…
Back to Monopar Therapeutics Inc.
How Monopar Therapeutics Inc. stacks up
MNPR · against 557 other Healthcare companies listed in US-listed
Profitability
23/ 100
Below the middle of the pack.
Ranked #306 of 558 · scores higher than 44% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including MNPR · Click a bar to see the companies
Why profitability scores 23?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -22.4% vs peer median 4.7%
- a lower return on assets: weaker than 77% of peers. Return on assets: -13.2% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = MNPR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MNPR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -22.4% | -7.0% | 40% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -13.2% | -7.8% | 44% | 33% | |
| Return on equityHigher is better · 531 reported | -19.5% | -19.7% | 50% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around MNPR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 298 | 513M USD | 24 | 31 | |
| 298 | 2.0B USD | 24 | 42 | |
| 306 | 471M USD | 23 | 21 | |
| 306 | 4.2B USD | 23 | 44 | |
| 306 | 469M USD | 23 | 50 | |
| 306 | 107M USD | 23 | 26 | |
| 306 | 9.0B USD | 23 | 33 | |
| 306 | 595M USD | 23 | 29 | |
| 312 | 2.2B USD | 22 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score